Type 2 diabetes represents an increased risk of a type of liver cancer known as hepatocellular carcinoma, hepatoma or HCC.
Researchers from the Keck School of Medicine at the University of Southern California reviewed data from the Multiethnic Cohort Study which included over 150,000 medical records. The clinical study enrolled participants between 1993 and 1996 and included a follow up after 15 years.
The research found that patients with type 2 diabetes have a 2 to 3 times higher risk for hepatocellular carcinoma than those without the condition. The study also found increased risks amongst a number of different ethnic groups. Notably, Latin Americans had a 2.8 times greater risk of HCC compared with non-hispanic caucasians and African Americans had 2.2 times increase in risk.
The biggest risk factor for hepatoma is having fatty liver disease, a health complication more commonly found in people with type 2 diabetes. Increased risks of HCC have previously been found in people of Lati, African and Asian origin and this form of liver cancer is between 4 and 8 times more common in men.
The researchers stress that HCC is a rarer form of cancer and affects around 4 in every 100,000 people in the UK. However, cases of this form of cancer are on the increase and have trebled within the last three decades.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…